Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

SELL
$6.01 - $8.93 $165,275 - $245,575
-27,500 Reduced 25.44%
80,600 $494,000
Q2 2023

Aug 14, 2023

BUY
$3.94 - $6.27 $177,674 - $282,745
45,095 Added 71.57%
108,100 $676,000
Q1 2023

May 15, 2023

BUY
$4.77 - $9.16 $206,851 - $397,223
43,365 Added 220.8%
63,005 $300,000
Q4 2022

Feb 14, 2023

SELL
$8.17 - $12.95 $10,482 - $16,614
-1,283 Reduced 6.13%
19,640 $170,000
Q3 2022

Nov 14, 2022

BUY
$11.4 - $17.18 $75,217 - $113,353
6,598 Added 46.06%
20,923 $249,000
Q2 2022

Aug 15, 2022

SELL
$9.23 - $22.43 $180,677 - $439,067
-19,575 Reduced 57.74%
14,325 $204,000
Q2 2021

Aug 12, 2021

BUY
$28.01 - $36.01 $434,155 - $558,155
15,500 Added 84.24%
33,900 $1.16 Million
Q1 2021

May 17, 2021

BUY
$30.66 - $49.5 $564,144 - $910,800
18,400 New
18,400 $605,000

Others Institutions Holding PMVP

About PMV Pharmaceuticals, Inc.


  • Ticker PMVP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,622,600
  • Market Cap $73.5M
  • Description
  • PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586, a small molecule that corrects a p53 protein containing the Y220C mutation and restores wild-type p53 function. It is also d...
More about PMVP
Track This Portfolio

Track State Of Wisconsin Investment Board Portfolio

Follow State Of Wisconsin Investment Board and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Wisconsin Investment Board, based on Form 13F filings with the SEC.

News

Stay updated on State Of Wisconsin Investment Board with notifications on news.